Mushrooms, tumors, and immunity.
暂无分享,去创建一个
M. Gershwin | C. Keen | J. Stern | A T Borchers | C L Keen | J S Stern | M E Gershwin | A. Borchers | R. Hackman | R M Hackman | J. Stern
[1] R. Bronson,et al. Dietary supplementation with mushroom-derived protein-bound glucan does not enhance immune function in young and old mice. , 1998, The Journal of nutrition.
[2] A. Flower,et al. Clinical Manual of Chinese Herbal Medicine and Acupuncture , 1996 .
[3] H. Saitǒ,et al. Antitumor‐active substances from mushrooms , 1995 .
[4] D. Sabolović,et al. Effect of a protein bound polysaccharide (PS-K) on tumor development and infections in splenectomized rats and mice. , 1986, International journal of immunopharmacology.
[5] N. Iizuka,et al. In vitro and in vivo analysis of human leukocyte binding by the antitumor polysaccharide, lentinan. , 1996, International journal of immunopharmacology.
[6] Takuma Sasaki,et al. Inhibition of Mouse Sarcoma 180 by Polysaccharides from Lentinus edodes (Berk.) Sing. , 1969, Nature.
[7] Y. O'hara. [Fate of lentinan (antitumor polysaccharide) I : - fate of lentinan in mice, rats, and dogs (author's transl)]. , 1980, The Journal of toxicological sciences.
[8] J. Hamuro,et al. Reconstitution of Anti‐tumor Effects of Lentinan in Nude Mice: Roles of Delayed‐type Hypersensitivity Reaction Triggered by CD4‐positive T Cell Clone in the Infiltration of Effector Cells into Tumor , 1994, Japanese journal of cancer research : Gann.
[9] Y. Adachi,et al. Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa. , 1994, Biological & pharmaceutical bulletin.
[10] S. Takeuchi,et al. Clinical evaluation of schizophyllan combined with irradiation in patients with cervical cancer: A randomized controlled study , 1986, Cancer.
[11] H. Tagoh,et al. An in vivo Study of Hepatic and Splenic Interleukin‐lβ mRNA Expression Following Oral PSK or LEM Administration , 1994, Japanese journal of cancer research : Gann.
[12] H. Yonekawa,et al. Polygenic control of the expression of biological activities of an antitumor polysaccharide, lentinan. , 1997, International journal of immunopharmacology.
[13] H. Nanba,et al. Antitumor action of shiitake (Lentinus edodes) fruit bodies orally administered to mice. , 1987, Chemical & pharmaceutical bulletin.
[14] H. Nanba,et al. Antitumor mechanisms of orally administered shiitake fruit bodies. , 1987, Chemical & pharmaceutical bulletin.
[15] Y. Adachi,et al. Activation of murine kupffer cells by administration with gel-forming (1-->3)-beta-D-glucan from Grifola frondosa. , 1998, Biological & pharmaceutical bulletin.
[16] T. Mizuno,et al. Reishi, Ganoderma lucidum and Ganoderma tsugae: bioactive substances and medicinal effects , 1995 .
[17] T. Kiho,et al. Tochukaso (Semitake and others), Cordyceps species , 1995 .
[18] E. Kishida,et al. Straw mushroom, Fukurotake, Volvariella volvacea , 1995 .
[19] Shu-Ting Chang,et al. Mushroom Biology: Concise Basics And Current Developments , 1997 .
[20] C. Schlatter,et al. Genotoxicity of agaritine in the lacI transgenic mouse mutation assay: evaluation of the health risk of mushroom consumption. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[21] R. Herberman,et al. The effect of lentinan on production of interleukin-1 by human monocytes. , 1982, Immunopharmacology.
[22] N. Volpi. Physico-Chemical Properties and the Structure of Dermatan Sulfate Fractions Purified from Plasma after Oral Administration in Healthy Human Volunteers , 1996, Thrombosis and Haemostasis.
[23] H. Fujita,et al. Triple helix of aschizophyllum commune polysaccharide in aqueous solution , 1980 .
[24] W. J. Visek,et al. Carcinogenesis studies with the lyophilized mushroom Agaricus bisporus in mice. , 1998, In vivo.
[25] H. Tomoda,et al. Usefulness of lymphocyte subset change as an indicator for predicting survival time and effectiveness of treatment with the immunopotentiator lentinan. , 1995, Anticancer research.
[26] H. Mashiba,et al. In vitro activation of human adherent cells by a glucan, Schizophyllan. , 1983, The Japanese journal of experimental medicine.
[27] K. Amemiya,et al. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG). , 1982, The Japanese journal of experimental medicine.
[28] J. Fachet,et al. Effect of lentinan on tumor growth in murine allogeneic and syngeneic hosts , 1980, International journal of cancer.
[29] T. Yadomae,et al. Antitumor and immunomodulating activities of a beta-glucan obtained from liquid-cultured Grifola frondosa. , 1989, Chemical & pharmaceutical bulletin.
[30] G. Abel,et al. Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1β , 1992 .
[31] B. Tóth,et al. Cancer induction in mice by feeding of the uncooked cultivated mushroom of commerce Agaricus bisporus. , 1986, Cancer research.
[32] Y. O'hara. FATE OF LENTINAN (ANTITUMOR POLYSACCHARIDE) II : Fate of Methyl Lentinan in Rats , 1980 .
[33] Y. Adachi,et al. Enhancement of LPS triggered TNF-alpha (tumor necrosis factor-alpha) production by (1-->3)-beta-D-glucans in mice. , 1995, Biological & pharmaceutical bulletin.
[34] Y. Adachi,et al. Effect of beta-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. , 1996, Biological & pharmaceutical bulletin.
[35] K. Takeda,et al. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer. , 1994, Acta oto-laryngologica. Supplementum.
[36] K. Austen,et al. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway. , 1985, Journal of immunology.
[37] M. Mitani,et al. Pharmacological and toxicological studies of a new antitumor polysaccharide, schizophyllan. , 1982, Arzneimittel-Forschung.
[38] T. Yadomae,et al. Inhibition of experimental pulmonary metastasis of Lewis lung carcinoma by orally administered beta-glucan in mice. , 1991, Chemical & pharmaceutical bulletin.
[39] K. Orita,et al. Enhancement of antitumor cytotoxicity of hepatic lymphocytes by oral administration of PSK. , 1994, International journal of immunopharmacology.
[40] R. Chang,et al. Functional properties of edible mushrooms. , 2009, Nutrition reviews.
[41] N. Ohno,et al. Effect of activation or blockade of the phagocytic system on the antitumor activity of grifolan. , 1986, Chemical & pharmaceutical bulletin.
[42] J. Fachet,et al. Effect of lentinan on pinocytosis in mouse peritoneal macrophages and the murine macrophage cell line C4M phi in vitro. , 1986, International journal of immunopharmacology.
[43] H. Koprowski,et al. Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors is stimulated by lentinan. , 1985, Japanese journal of cancer research : Gann.
[44] T. Ikekawa. Enokitake, Flammulina velutipes: Host‐mediated antitumor polysaccharides , 1995 .
[45] B. Tóth,et al. Lack of carcinogenesis by the baked mushroom Agaricus bisporus in mice: different feeding regimen [corrected]. , 1997, In vivo.
[46] L. Tankó,et al. Strain differences in the cytotoxic activity and TNF production of murine macrophages stimulated by lentinan. , 1996, International journal of immunopharmacology.
[47] T. Mizuno. Bioactive biomolecules of mushrooms: Food function and medicinal effect of mushroom fungi , 1995 .
[48] K. Matsumoto,et al. Carcinogenicity examination of Agaricus bisporus, edible mushroom, in rats. , 1991, Cancer letters.
[49] T. Mizuno,et al. Niohshimeji, Tricholoma giganteum: Antitumor‐active heteroglycans , 1995 .
[50] Y. Adachi,et al. Characterization of the antitumor glucan obtained from liquid-cultured Grifola frondosa. , 1986, Chemical & pharmaceutical bulletin.
[51] H. Maeda,et al. Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes. , 1978, The Journal of antibiotics.
[52] H. Fujita,et al. Correlation between the antitumor activity of a polysaccharide schizophyllan and its triple-helical conformation in dilute aqueous solution. , 1983, Biophysical chemistry.
[53] N. Ohno,et al. Effect of glucans on the antitumor activity of grifolan. , 1986, Chemical & pharmaceutical bulletin.
[54] J. Peberdy,et al. Lignocellulolytic enzyme profiles of edible mushroom fungi , 1996, World journal of microbiology & biotechnology.
[55] J. Hamuro,et al. Lentinan augments skin reaction induced by bradykinin: its correlation with vascular dilatation and hemorrhage responses and antitumor activities. , 1995, International journal of immunopharmacology.
[56] K. Austen,et al. Lysosomal enzyme release from human monocytes by particulate activators is mediated by beta-glucan inhibitable receptors. , 1987, Journal of immunology.
[57] M. Nagamatsu,et al. Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma. , 1992, International journal of immunopharmacology.
[58] H. Nanba,et al. Potentiation of host-mediated antitumor activity by orally administered mushroom (Agaricus bispora) fruit bodies. , 1988, Chemical & pharmaceutical bulletin.
[59] J. Fachet,et al. Effect of lentinan and mannan on phagocytosis of fluorescent latex microbeads by mouse peritoneal macrophages: a flow cytometric study. , 1989, International journal of immunopharmacology.
[60] T. Mizuno,et al. Fractionation and Characterization of Antitumor Polysaccharides from Maitake, Grifola frondosa , 1986 .
[61] A. Conte,et al. Metabolic fate of exogenous chondroitin sulfate in the experimental animal. , 1990, Arzneimittel-Forschung.
[62] T. Suga,et al. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. , 1984, Cancer research.
[63] S. Fujimoto,et al. Augmentation of Anti‐tumor Immunity in Low‐responder Mice by Various Biological Response Modifiers: Analysis of Effector Mechanism , 1989, Japanese journal of cancer research : Gann.
[64] H. Inoue,et al. Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. , 1992, International journal of immunopharmacology.
[65] K. Kimura,et al. Host-mediated antitumor action of schizophyllan, a glucan produced by Schizophyllum commune. , 1969, Gan.
[66] W. Breene. Nutritional and Medicinal Value of Specialty Mushrooms. , 1990, Journal of food protection.
[67] N. Ohno,et al. Structural characterization and antitumor activity of the extracts from matted mycelium of cultured Grifola frondosa. , 1985, Chemical & pharmaceutical bulletin.
[68] A. Misaki,et al. Kikurage (Tree‐ear) and Shirokikurage (white Jelly‐leaf): Auricularia auricula and Tremella fuciformis , 1995 .
[69] N. Ohno,et al. Modification of immunostimulating activities of grifolan by the treatment with (1----3)-beta-D-glucanase. , 1989, Journal of pharmacobio-dynamics.
[70] H. Yonekawa,et al. Genetical control on lentinan-induced acute phase responses and vascular responses. , 1992, Folia histochemica et cytobiologica.
[71] Y. Adachi,et al. Kupffer cells play important roles in the metabolic degradation of a soluble anti-tumor (1-->3)-beta-D-glucan, SSG, in mice. , 1996, FEMS immunology and medical microbiology.
[72] Shu-Ting Chang,et al. Edible mushrooms and their cultivation , 1989 .
[73] N. Ohno,et al. Effect of soluble fungal (1-->3)-beta-D-glucan obtained from Sclerotinia sclerotiorum on alveolar macrophage activation. , 1995, Immunopharmacology.
[74] H. Wakasugi,et al. Lentinan potentiates immunity and prolongs the survival time of some patients. , 1997, Anticancer research.
[75] N. Ohno,et al. Oxidative degradation of an antitumor (1-3)-beta-D-glucan, grifolan. , 1991, Journal of pharmacobio-dynamics.
[76] Y. Adachi,et al. Tissue distribution of intraperitoneally administered (1-->3)-beta-D-glucan (SSG), a highly branched antitumor glucan, in mice. , 1992, Journal of pharmacobio-dynamics.
[77] T. N. Kaul. Introduction to mushroom science : systematics , 1997 .
[78] N. Ohno,et al. Modulation of antitumor activity of grifolan by subsequent administration of (1----3)-beta-D-glucanase in vivo. , 1989, Journal of pharmacobio-dynamics.
[79] N. Takasuka,et al. Further study of the structure of lentinan, an anti-tumor polysaccharide from Lentinus edodes. , 1976, Carbohydrate research.
[80] T. Nakano,et al. Intratumoral administration of sizofiran activates Langerhans cell and T-cell infiltration in cervical cancer. , 1996, Clinical immunology and immunopathology.
[81] T. Suga,et al. Synergistic Antimetastatic Effects of Lentinan and Interleukin 2 with Pre‐ and Post‐operative Treatments , 1994, Japanese journal of cancer research : Gann.
[82] H. Katabuchi,et al. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival. , 1995, Gynecologic oncology.
[83] Y. Adachi,et al. Change of biological activities of (1----3)-beta-D-glucan from Grifola frondosa upon molecular weight reduction by heat treatment. , 1990, Chemical & pharmaceutical bulletin.